Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT

[1]  A. Girolami,et al.  Congenital FVII Deficiency and Pulmonary Embolism , 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[2]  G. Lippi,et al.  Inherited disorders of blood coagulation , 2012, Annals of medicine.

[3]  G. Lippi,et al.  Acquired Inhibitors of Coagulation Factors: Part II , 2012, Seminars in Thrombosis & Hemostasis.

[4]  P. Mannucci,et al.  Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[5]  M. Khamashta,et al.  Intensity and Duration of Anticoagulation Therapy in Antiphospholipid Syndrome , 2012, Seminars in Thrombosis & Hemostasis.

[6]  M. Galli.  Interpretation and Recommended Testing for Antiphospholipid Antibodies , 2012, Seminars in Thrombosis & Hemostasis.

[7]  A. Ruffatti,et al.  What Have We Learned about Antiphospholipid Syndrome from Patients and Antiphospholipid Carrier Cohorts? , 2012, Seminars in Thrombosis & Hemostasis.

[8]  G. Espinosa,et al.  Update on the Catastrophic Antiphospholipid Syndrome and the “CAPS Registry” , 2012, Seminars in Thrombosis & Hemostasis.

[9]  J. Vandenbroucke,et al.  Relationship between Venous and Arterial Thrombosis: A Review of the Literature from a Causal Perspective , 2011, Seminars in thrombosis and hemostasis.

[10]  A. Iorio,et al.  Impact of Persistent Antiphospholipid Antibodies on Risk of Incident Symptomatic Thromboembolism in Children: A Systematic Review and Meta-Analysis , 2011, Seminars in thrombosis and hemostasis.

[11]  G. Lippi,et al.  Arterial thrombus formation in cardiovascular disease , 2011, Nature Reviews Cardiology.

[12]  B. Sullenger,et al.  The many faces of the contact pathway and their role in thrombosis , 2011, Journal of Thrombosis and Thrombolysis.

[13]  J. Fareed,et al.  Antiphospholipid syndrome and pre-eclampsia. , 2011, Seminars in thrombosis and hemostasis.

[14]  I. Uthman,et al.  Antiphospholipid Syndrome: Endocrinologic Manifestations and Organ Involvement , 2011, Seminars in thrombosis and hemostasis.

[15]  D. Tregouet,et al.  The factor XII -4C>T variant and risk of common thrombotic disorders: A HuGE review and meta-analysis of evidence from observational studies. , 2011, American journal of epidemiology.

[16]  E. Lindhoff‐Last,et al.  New aspects of paradoxical embolism. , 2011, VASA. Zeitschrift fur Gefasskrankheiten.

[17]  E. Favaloro,et al.  Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays , 2011, Clinical chemistry and laboratory medicine.

[18]  G. Lippi,et al.  Coagulopathies and thrombosis: usual and unusual causes and associations, Part IV. , 2011, Seminars in thrombosis and hemostasis.

[19]  G. Lippi,et al.  Coagulopathies and thrombosis: usual and unusual causes and associations. Part V. , 2011, Seminars in thrombosis and hemostasis.

[20]  E. Favaloro,et al.  The antiphospholipid syndrome: a large elephant with many parts or an elusive chameleon disguised by many colours? , 2010, Autoimmunity Highlights.

[21]  Evi X. Stavrou,et al.  Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis. , 2010, Thrombosis research.

[22]  F. Boehlen,et al.  Fibrinogen and the Risk of Thrombosis , 2010, Seminars in thrombosis and hemostasis.

[23]  A. Iorio,et al.  Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors. , 2010, The Cochrane database of systematic reviews.

[24]  G. Lippi,et al.  The role of ethnicity, age and gender in venous thromboembolism , 2010, Journal of Thrombosis and Thrombolysis.

[25]  G. Lippi,et al.  Unsuspected Triggers of Venous Thromboembolism—Trivial or Not So Trivial? , 2009, Seminars in thrombosis and hemostasis.

[26]  G. Mariani,et al.  Factor VII Deficiency , 2009, Seminars in thrombosis and hemostasis.

[27]  P. de Moerloose,et al.  Congenital Fibrinogen Disorders , 2009, Seminars in thrombosis and hemostasis.

[28]  F. Rodeghiero,et al.  Severe spontaneous arterial thrombotic manifestations in patients with inherited hypo‐ and afibrinogenemia , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

[29]  A. Girolami,et al.  Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature , 2009, Journal of Thrombosis and Thrombolysis.

[30]  G. Lippi,et al.  Antithrombotic prophylaxis in patients with von Willebrand disease undergoing major surgery: when is it necessary? , 2009, Journal of Thrombosis and Thrombolysis.

[31]  G. Lessiani,et al.  Deep venous thrombosis and previous myocardial infarction in mild factor XII deficiency: a risk factor for both venous and arterial thrombosis , 2009, Journal of Thrombosis and Thrombolysis.

[32]  G. Lippi,et al.  Pathogenesis of venous thromboembolism: when the cup runneth over. , 2008, Seminars in thrombosis and hemostasis.

[33]  M. Franchini.  Surgical prophylaxis in von Willebrand's disease: a difficult balance to manage. , 2008, Blood transfusion = Trasfusione del sangue.

[34]  J. Schved,et al.  The paradoxical association between inherited factor VII deficiency and venous thrombosis , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[35]  P. de Mazancourt,et al.  Afibrinogenemia resulting from homozygous nonsense mutation in A alpha chain gene associated with multiple thrombotic episodes , 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[36]  Chan Jun-mi,et al.  International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome(APS) , 2008 .

[37]  B. Jilma,et al.  Evidence of a U‐shaped association between factor XII activity and overall survival , 2007, Journal of thrombosis and haemostasis : JTH.

[38]  Frits R Rosendaal,et al.  Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII. , 2006, Blood.

[39]  A. Girolami,et al.  Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[40]  M. Franchini.  Thrombotic complications in patients with hereditary bleeding disorders , 2004, Thrombosis and Haemostasis.

[41]  M. Franchini,et al.  Absence of thromboembolic complications in patients with hereditary bleeding disorders undergoing major orthopaedic surgery without antithrombotic prophylaxis. , 2004, Thrombosis and haemostasis.

[42]  A. Lombardi,et al.  The Occasional Venous Thromboses Seen in Patients with Severe (Homozygous) FXII Deficiency are Probably Due to Associated Risk Factors: A Study of Prevalence in 21 Patients and Review of the Literature , 2004, Journal of Thrombosis and Thrombolysis.

[43]  M. Winter,et al.  Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis. , 2004, Thrombosis research.

[44]  J. Astermark,et al.  Thrombosis in inherited factor VII deficiency , 2003, Journal of thrombosis and haemostasis : JTH.

[45]  T. Barbui,et al.  Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. , 2003, Blood.

[46]  G. Lippi,et al.  Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease. , 2003, Haematologica.

[47]  M. Makris,et al.  Venous Thrombosis Following the Use of Intermediate Purity FVIII Concentrate to Treat Patients with Von Willebrand’s Disease , 2002, Thrombosis and Haemostasis.

[48]  P. Mannucci,et al.  Venous Thromboembolism in Von Willebrand Disease , 2002, Thrombosis and Haemostasis.

[49]  P. Mannucci,et al.  Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study. , 2002, Blood.

[50]  G. Lowe.  Factor IX and thrombosis , 2001, British journal of haematology.

[51]  G. Lippi,et al.  Preoperative screening: the rationale of measuring APTT in risk assessment. , 2001, Haematologica.

[52]  P. Reitsma,et al.  High Plasma Concentration of Factor VIIIc Is a Major Risk Factor for Venous Thromboembolism , 2000, Thrombosis and Haemostasis.

[53]  P. Mannucci,et al.  Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia , 1999, British journal of haematology.

[54]  C. Soria,et al.  Severe arterial thrombosis in a congenitally factor VII deficient patient , 1995, British journal of haematology.

[55]  B. Djulbegovic.  Lack of prophylactic anticoagulant therapy is not associated with clinical thrombotic complications in patients with hemophilia who undergo orthopedic surgical procedures , 1995, American journal of hematology.

[56]  J. Vandenbroucke,et al.  Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis , 1995, The Lancet.

[57]  P. Mannucci,et al.  Markers of Hypercoagulability in Patients with Hemophilia B Given Repeated, Large Doses of Factor IX Concentrates during and after Surgery , 1994, Thrombosis and Haemostasis.

[58]  C. Mannhalter,et al.  [Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction]. , 1993, Wiener medizinische Wochenschrift.

[59]  M. Poon,et al.  Deep venous thrombosis in hemophilia A. , 1992, The American journal of medicine.

[60]  J. Lusher,et al.  Thrombogenicity associated with factor IX complex concentrates. , 1991, Seminars in hematology.

[61]  E. Geltman,et al.  Unstable angina associated with factor VIII concentrate therapy for hemophilia A. , 1986, Annals of internal medicine.

[62]  Imre Horváth,et al.  2 – Critical review of the literature , 1984 .

[63]  O. Ratnoff,et al.  A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. , 1955, The Journal of clinical investigation.